Key result
Emergent PCI proves feasible and safe in a COVID-19 patient presenting with anterior STEMI.
Why the study?
The clinical management and safety of emergent percutaneous coronary intervention in COVID-19 patients with acute myocardial infarction require detailed description.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
Emergent PCI is feasible and safe in COVID-19 patients presenting with STEMI, though it requires a multidisciplinary approach.
BACKGROUND: Coronavirus disease-2019 (COVID-19) is an infectious disease appeared in China in December 2019 and, since then, has spread worldwide at a rapid pace. CASE SUMMARY: A patient with COVID-19 was hospitalized in our institution for a diabetic foot ulcer and presented afterwards a pulmonary oedema and concomitant anterior ST-segment elevation myocardial infarction. We report here on the initial presentation, coronary care and intervention, and clinical course of this patient. DISCUSSION: Emergent percutaneous coronary intervention is feasible and safe in COVID-19 patients but requires a multidisciplinary effort involving caregivers from infectious disease, intensive care, and cardiology teams.
No takes yet. Share an insight, caveat, or question.
Fischer et al. (2020) conducted a case report in COVID-19 and anterior ST-elevation myocardial infarction (n=1). Emergent percutaneous coronary intervention was evaluated on Clinical course and safety of emergent PCI. Emergent percutaneous coronary intervention was feasible and safe in a COVID-19 patient presenting with anterior STEMI.
Synapse has enriched 10 related papers. Consider them for comparative context: